Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report
- PMID: 34180372
- DOI: 10.1080/10550887.2021.1945398
Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report
Abstract
In this case report, we described a patient admitted with persistent methamphetamine-induced psychotic symptoms, accompanied by negative symptoms, who appeared to respond to cariprazine treatment regarding his psychotic and craving symptoms. To our knowledge, no cariprazine-related data has been published about these type of patients. Our case suggests that cariprazine may improve both psychotic and addictive symptoms in subjects with persistent substance-induced psychotic disorders. Notably, our patient reported an abrupt decrease in substance craving and use, and an improvement in positive and negative psychotic symptoms. Although it is not possible to generalize the observations and findings gathered with this single case, it detected a potential effect of cariprazine on a drug naïve patient with persistent psychotic symptoms induced by methamphetamine for the first time.
Keywords: Cariprazine; methamphetamine; psychosis.
Similar articles
-
First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.Schizophr Res. 2018 Sep;199:456-457. doi: 10.1016/j.schres.2018.04.021. Epub 2018 Apr 18. Schizophr Res. 2018. PMID: 29680188 No abstract available.
-
Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.Am J Psychiatry. 2010 Jan;167(1):17-23. doi: 10.1176/appi.ajp.2009.08111695. Am J Psychiatry. 2010. PMID: 20068123 Review.
-
A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.Int J Psychiatry Clin Pract. 2013 Jun;17(2):131-8. doi: 10.3109/13651501.2012.667116. Epub 2012 Apr 10. Int J Psychiatry Clin Pract. 2013. PMID: 22486597 Clinical Trial.
-
Case Series: Cariprazine for treatment of methamphetamine use disorder.Am J Addict. 2022 Jan;31(1):85-88. doi: 10.1111/ajad.13241. Epub 2021 Oct 29. Am J Addict. 2022. PMID: 34713943
-
Methamphetamine psychosis: insights from the past.Addiction. 2018 Aug;113(8):1522-1527. doi: 10.1111/add.14170. Epub 2018 Mar 8. Addiction. 2018. PMID: 29516555 Review.
Cited by
-
Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review.Healthcare (Basel). 2024 Jan 29;12(3):339. doi: 10.3390/healthcare12030339. Healthcare (Basel). 2024. PMID: 38338224 Free PMC article. Review.
-
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study.Front Psychiatry. 2023 Dec 4;14:1321233. doi: 10.3389/fpsyt.2023.1321233. eCollection 2023. Front Psychiatry. 2023. PMID: 38111619 Free PMC article.
-
A Case Report of Treatment With Cariprazine in a Recurrent Psychosis Presumably Induced by Methamphetamine.Cureus. 2023 Oct 16;15(10):e47135. doi: 10.7759/cureus.47135. eCollection 2023 Oct. Cureus. 2023. PMID: 38021522 Free PMC article.
-
Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report.Int J Environ Res Public Health. 2022 Nov 30;19(23):16057. doi: 10.3390/ijerph192316057. Int J Environ Res Public Health. 2022. PMID: 36498129 Free PMC article.
-
Case Report: Functional and Symptomatic Improvement With Cariprazine in Various Psychiatric Patients: A Case Series.Front Psychiatry. 2022 Aug 1;13:878889. doi: 10.3389/fpsyt.2022.878889. eCollection 2022. Front Psychiatry. 2022. PMID: 35978843 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical